IL10, interleukin 10, 3586

N. diseases: 1679; N. variants: 21
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0019163
Disease: Hepatitis B
Hepatitis B
0.100 GeneticVariation disease BEFREE These results suggest that IL10 and IL20 gene variants influence HBV infection outcome and encourage the pursuit of further studies of these cytokines in HBV pathogenesis. 18479293 2008
CUI: C0019163
Disease: Hepatitis B
Hepatitis B
0.100 Biomarker disease BEFREE Whereas TBE and hepatitis B nonresponders had increased IL-10-producing FOXP3(+) T regulatory cells upon vaccination, only in hepatitis B nonresponders, showing elevated prevaccination IL-10 levels, a prominent population of B regulatory cells was detected. 23872054 2013
CUI: C0019163
Disease: Hepatitis B
Hepatitis B
0.100 GeneticVariation disease BEFREE Persistent HBV infection susceptibility is associated with the gene polymorphism IL-10 -1082GA in the Chinese population and the clearance of HBV is associated with the gene polymorphism IL-10 -592CA in the Chinese population. 21246248 2011
CUI: C0019163
Disease: Hepatitis B
Hepatitis B
0.100 AlteredExpression disease BEFREE Increased IL10 production mediated by IL10-ht2 suggests that up-regulated IL10 accelerates progression of chronic HBV infection, especially to HCC development. 12668613 2003
CUI: C0019163
Disease: Hepatitis B
Hepatitis B
0.100 GeneticVariation disease LHGDN Evaluation of IL10, IL19 and IL20 gene polymorphisms and chronic hepatitis B infection outcome. 18479293 2008
CUI: C0019163
Disease: Hepatitis B
Hepatitis B
0.100 GeneticVariation disease BEFREE Genotypes A/A, A/G and G/G of IL-10-1082 were detected in CHB patients and individuals with self-limited HBV infection; however, genotype G/G had not been detected in normal controls. 27245049 2016
CUI: C0019163
Disease: Hepatitis B
Hepatitis B
0.100 GeneticVariation disease LHGDN The IL-10 genotype (polymorphic bases at positions -1082 and -819) was determined in 272 chronic hemodialysis patients using highly specific PCR and related to the patients' response to a triple vaccination against hepatitis B. Secretion of IL-10 and IL-6 by peripheral blood leucocytes in vitro was determined by ELISA. 11737614 2001
CUI: C0019163
Disease: Hepatitis B
Hepatitis B
0.100 GeneticVariation disease BEFREE The presence of low producing IL-10-1082A and -592A alleles and their containing genetic variants protect highly exposed IDUs against acquisition of HIV and HBV infections. 25542814 2015
CUI: C0019163
Disease: Hepatitis B
Hepatitis B
0.100 GeneticVariation disease BEFREE The IL-10 promoter polymorphism at position -592 is correlated with susceptibility to occult HBV infection. 21901441 2012
CUI: C0019163
Disease: Hepatitis B
Hepatitis B
0.100 AlteredExpression disease BEFREE Moreover, there was a positive correlation between serum levels of IL-9 and IL-10 and HBV DNA loads in patients with chronic HBV infection. 28481430 2018
CUI: C0019163
Disease: Hepatitis B
Hepatitis B
0.100 Biomarker disease BEFREE In addition, the serum IL-10 were negatively correlated with the frequency of Th17 cells in PBMC from patients with chronic HBV infection (r=-0.452, P < 0.01). 20492330 2010
CUI: C0019163
Disease: Hepatitis B
Hepatitis B
0.100 Biomarker disease BEFREE Whether the same occurs during acute hepatitis B virus (HBV) infection and role that IL-10 might play in liver disease is currently unknown. 28483675 2017
CUI: C0019163
Disease: Hepatitis B
Hepatitis B
0.100 AlteredExpression disease BEFREE These data suggest that the frequencies of Bregs and levels of serum IL-10 were different in various immune phases in patients with chronic HBV infection. 28715645 2017
CUI: C0019163
Disease: Hepatitis B
Hepatitis B
0.100 Biomarker disease BEFREE The IL-10 gene promoter -592 C/C genotype was related to clearance of HBV infection in logistic regression analysis after adjusting for age and sex (P = 0.003). 16824070 2006
CUI: C0019163
Disease: Hepatitis B
Hepatitis B
0.100 GeneticVariation disease BEFREE We conducted a case-control study to investigate the role of three common single nucleotide polymorphisms of IL-10 (-592G/A, -819T/C, and -1082A/C) in the development of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). 27050962 2016
CUI: C0019163
Disease: Hepatitis B
Hepatitis B
0.100 Biomarker disease BEFREE IL-10 may be an underlying predictor and treatment target of hepatitis B, and further studies are needed. 31725660 2019
CUI: C0019163
Disease: Hepatitis B
Hepatitis B
0.100 Biomarker disease BEFREE There was no difference in the HBV DNA levels during hepatitis flares between patients with genotypes B and C. Patients with genotype B had a significantly higher number of IFN-gamma producing cells [with hepatitis B core antigen (HBcAg) stimulation] and lower number of IL-10 producing cells (with HBcAg and HBeAg stimulation) compared with patients with genotype C (P = 0.011, =0.043, <0.001 respectively). 17381719 2007
CUI: C0019163
Disease: Hepatitis B
Hepatitis B
0.100 GeneticVariation disease BEFREE Tag single nucleotide polymorphisms (SNPs) were used to investigate the relationship between IL-10 gene polymorphisms and susceptibility to chronic hepatitis B virus (HBV) infection by comparing 996 chronic HBV infection cases to 301 acute infection controls. 24631780 2014
CUI: C0019163
Disease: Hepatitis B
Hepatitis B
0.100 GeneticVariation disease BEFREE These preliminary results suggest a strong association of IL10 (-819/-592) with the HBV infection mediated disease progression, from inactive carrier state to malignancy, in Indian population. 25027084 2014
CUI: C0019163
Disease: Hepatitis B
Hepatitis B
0.100 GeneticVariation disease BEFREE IL-10 gene promoter polymorphisms significantly influence the mode and sequel of HBeAg seroconversion in patients with chronic HBV infection. 16584395 2006
CUI: C0019163
Disease: Hepatitis B
Hepatitis B
0.100 Biomarker disease BEFREE In contrast, the Th2 cytokine IL-10 serves as a potent inhibitor of Th1 effector cells in HBV diseases. 12679901 2003
CUI: C0019163
Disease: Hepatitis B
Hepatitis B
0.100 Biomarker disease BEFREE The IL-10 genotype (polymorphic bases at positions -1082 and -819) was determined in 272 chronic hemodialysis patients using highly specific PCR and related to the patients' response to a triple vaccination against hepatitis B. Secretion of IL-10 and IL-6 by peripheral blood leucocytes in vitro was determined by ELISA. 11737614 2001
CUI: C0019163
Disease: Hepatitis B
Hepatitis B
0.100 GeneticVariation disease BEFREE Risk for low anti-HBs titers decreased with concurrent decreases in glucose ante cibum (AC, before meals) and the IL-10 ACC/ACC haplotype. 21238445 2011
CUI: C0019163
Disease: Hepatitis B
Hepatitis B
0.100 GeneticVariation disease BEFREE To investigate the association of interleukin (IL)-10 and IL-10 receptor A (IL-10RA) single nucleotide polymorphisms with the responsiveness to hepatitis B virus (HBV) vaccination in newborns whose mothers were hepatitis B surface antigen (HBsAg)(+)/hepatitis B e antigen (HBeAg)(-). 30498038 2018
CUI: C0019163
Disease: Hepatitis B
Hepatitis B
0.100 AlteredExpression disease BEFREE The start of immune-clearance phase, age at HBeAg seroconversion, and serum IL-10 and IL-12 levels are associated with the course of the immune-clearance phase in chronic HBV infection, and are predictive of spontaneous HBsAg seroconversion and HBV recovery. 25505294 2015